7 Feb 2023

Solving the Pre-Filled Syringes Mystery for Low Temperature Applications (-80°C)

New therapeutic treatments or prophylactic vaccines rely on more complicated drug formulations, often based on biologics. These drugs are highly sensitive and might require low temperature storage to keep them stable over shelf life. These extreme cold supply chain processes, something up to -80°C, provide a new challenge to pre-fillable syringes. In this presentation we will show you scientifically based argumentations and results to help you to select the right pre-fillable syringe for your low temperature application.

Content provided by our supplier

SCHOTT Pharma AG & Co. KGaA

  • DE
  • 2015
    On CPHI since

Other Content from SCHOTT Pharma AG & Co. KGaA (2)

  • News Pharma supply chain companies form alliance to accelerate sustainability

    Alliance to Zero aims to facilitate the transition of the pharma sector to reach net zero emissions target
  • Webinar End to End Sterility Assurance for Next Level Risk Mitigation

    In this webinar, originally broadcast as part of the Pharmapack Europe show, Dr. Robert Lindner, Global Product Manager RTU Vials, SCHOTT AG will discuss how sterile integrity is indispensable in aseptic fill-and-finish operations. Pharmaceutical companies pay highest attention to producing high quality drugs and safekeeping their efficacy during fill-and-Finish and beyond. The risks of contaminated batches leads to recalls, high costs, reputation loss and in the worst scenario may harm patients’ wellbeing. Hence, it is the pharma company’s obligation to ensure the sterility of all components when entering the aseptic filling core - which is possible, yet cumbersome with the RTU solutions that are currently available within the industry.